Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
about
Colorectal Cancer Biomarkers: Where Are We Now?Blood-based DNA methylation as biomarker for breast cancer: a systematic reviewDNA studies using atomic force microscopy: capabilities for measurement of short DNA fragmentsUsing circulating tumor cells to inform on prostate cancer biology and clinical utilityCirculating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancerGenetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNAHigh fragmentation characterizes tumour-derived circulating DNA.Liquid biopsy: monitoring cancer-genetics in the blood.Circulating free DNA in the management of breast cancer.Changes in mutational status during third-line treatment for metastatic colorectal cancer--results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma.Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.Multiparametric analysis of cell-free DNA in melanoma patientsCurrent challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarctionComplete genes may pass from food to human blood.Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerThe promise of methylation on beads for cancer detection and treatment.Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.Diagnostic potential of circulating cell-free DNA in patients needing mechanical ventilation: promises and challenges.Origin of Circulating Free DNA in Sepsis: Analysis of the CLP Mouse Model.Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic diseaseComparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.Plasma cell-free DNA in patients needing mechanical ventilation.Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer.Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistanceUltradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanomaRASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.Detecting circulating tumor cells: current challenges and new trends.Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology.The origin and properties of extracellular DNA: from PAMP to DAMP.
P2860
Q27003134-386C18C8-2C4A-4819-9C4E-31312B9D855CQ28072075-3FDAA96C-3189-4945-94D1-7D368798BF72Q28080979-E49F25A5-5D7A-4853-A72F-4E8CEBEBB0E4Q28083261-78FAF1F9-F382-4A5C-8243-5A909476A783Q33611481-80BE5A67-6E4D-42BB-BA86-7B250A688108Q33709786-897385E4-AD65-4BFA-8179-9D23B7E329B0Q34016528-1ED5E714-8D09-4C89-9E41-64CCBB77BC54Q34356149-04E51593-7411-4886-97AC-BC02DB20697DQ34357893-1524D101-33CA-4D65-A4BF-C51E27B970BEQ34411556-34E9E483-FDE9-4EC2-86CA-838D03CB78D5Q34421199-9DD34F07-2981-4361-9957-6E75D58749CAQ34499759-AE18E2F1-A192-4FD4-A0F0-27B780B59B54Q34577740-B6D32A91-BB15-4E70-8283-4FE2299522C3Q34599093-7298E891-86CC-4348-933D-F95EF20F164AQ34921290-B49ED4ED-2749-4C72-B5A7-2C0B52F60F1EQ35078470-EAFAFC20-BB42-4E77-80BB-89DC625A831CQ35212779-B2026DBA-3F0C-4414-A627-B94A5A05104AQ35576801-D0C8007F-AB43-4A46-B94C-9047BDB6F790Q35594733-90CF6165-6055-4617-831F-DE08C6C4379CQ35748716-133A4FBD-6B8C-480C-99D9-588E2ECAFAA8Q35839745-A339FAE1-D9EF-456E-A60D-2A039D5C8A7AQ35908039-CC2FDBCE-1558-4F10-AF4E-8269EE21E564Q35931077-38992BA7-4F8F-45E1-ADD7-FA6D45C5D125Q36000803-46984467-2B54-46BD-9200-CA4E1CF41BDDQ36008206-71CA3FB0-EAC1-43FF-9502-027576758B37Q36009225-504DA2A3-65E2-4C4E-918A-926B7412F045Q36070516-48C6E011-22D5-420C-BEEA-340BE6343A03Q36219131-0BAFCF70-54B3-44F9-9E80-6C70B3626F5CQ36247593-3B0E58E8-197E-44E5-A22E-FE2593301AA1Q36278010-8090E245-6F38-4706-86B6-61A6B5E1F169Q36318273-84E17D85-B4FE-45C1-8B9B-EF88AE580637Q36443927-907C85E2-CA50-498C-871B-78F6152A891AQ36597182-F14B6724-4398-414E-B4CF-C631ADA11121Q36764022-262897DD-B74B-4519-825E-5F8D1FE2B359Q36804878-C6AEF4F4-9BAD-4AEE-8955-930A0207264AQ36865048-2898C5F0-8DFB-4A77-A8D5-6119A167B7D9Q36865058-6449DE9A-B204-41A8-8AF1-8C087D3AFE3EQ36915318-58C1E4D4-B5AC-4CEE-A0ED-5A1026E5EE65Q37014663-90E04EA6-4954-4040-A3FB-CD9B0BADCCF6Q37047827-24C38859-9354-4D23-8F09-245A316523C8
P2860
Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cell-free DNA in the blood as ...... l appraisal of the literature.
@en
Cell-free DNA in the blood as ...... l appraisal of the literature.
@nl
type
label
Cell-free DNA in the blood as ...... l appraisal of the literature.
@en
Cell-free DNA in the blood as ...... l appraisal of the literature.
@nl
prefLabel
Cell-free DNA in the blood as ...... l appraisal of the literature.
@en
Cell-free DNA in the blood as ...... l appraisal of the literature.
@nl
P1433
P1476
Cell-free DNA in the blood as ...... al appraisal of the literature
@en
P2093
Anja Rabien
Michael Fleischhacker
P304
P356
10.1016/J.CCA.2010.07.032
P50
P577
2010-08-02T00:00:00Z